XBiotech Inc.
XBIT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626878
No open-market purchases or sales by XBiotech Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $4.56M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding XBiotech Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 64 | 1 | 56 | −7 |
| Shares | 4.03M | 1.84K | 3.36M | −670.6K (−16.6%) |
| Value | $34.9M | $16.0K | $18.9M | −$15.9M (−45.7%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held XBiotech Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Oasis Management Co Ltd. | 137,174 | $772.0K | 0.14% |
| Renaissance Technologies LLC | 78,668 | $443.0K | 0.00% |
| Ergoteles LLC | 70,114 | $395.0K | 0.01% |
| Acadian Asset Management LLC | 49,497 | $278.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 35,330 | $199.0K | 0.00% |
| Two Sigma Advisers, LP | 31,800 | $179.0K | 0.00% |
| Bridgeway Capital Management, LLC | 30,500 | $172.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 27,251 | $153.0K | 0.00% |
| Susquehanna International Group, LLP | 22,799 | $128.0K | 0.00% |
| Jump Financial, LLC | 18,538 | $104.0K | 0.00% |
| Qube Research & Technologies Ltd | 14,389 | $81.0K | 0.00% |
| Squarepoint Ops LLC | 11,189 | $63.0K | 0.00% |
| CWM, LLC | 28 | $0 | 0.00% |
| Lindbrook Capital, LLC | 66 | $0 | 0.00% |
Sold out (21)
Institutions that held XBiotech Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Nuveen Asset Management, LLC | 88,400 | $764.0K |
| Allspring Global Investments Holdings, LLC | 88,312 | $763.0K |
| Swiss National Bank | 46,800 | $404.0K |
| Alliancebernstein L.P. | 31,300 | $270.0K |
| AQR Capital Management LLC | 29,365 | $254.0K |
| California State Teachers Retirement System | 23,333 | $202.0K |
| STRS Ohio | 20,500 | $177.0K |
| Alberta Investment Management Corp | 19,500 | $168.0K |
| Rhumbline Advisers | 18,748 | $162.0K |
| Leonteq Securities AG | 13,000 | $112.3K |
| Caxton Associates LP | 10,309 | $89.0K |
| Deutsche Bank AG | 8,274 | $71.0K |
| American International Group, Inc. | 7,561 | $65.0K |
| Barclays PLC | 2,563 | $23.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,122 | $18.0K |
| Amalgamated Bank | 1,842 | $16.0K |
| High Net Worth Advisory Group LLC | 1,500 | $13.0K |
| Ameritas Investment Partners, Inc. | 1,143 | $10.0K |
| Russell Investments Group, Ltd. | 1,023 | $8.00K |
| Great West Life Assurance Co | 635 | $6.00K |
| Toronto Dominion Bank | 2 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held XBiotech Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 1,842 | $16.0K |